Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Background

We aimed to investigate antioxidant and neuroprotective properties of chlorogenic acid in spinal cord injury (SCI).

Methods

Twenty-one rats were divided into three groups. Laminectomy was performed in group L (n=7), spinal cord trauma was induced in group T (n=7), and spinal cord trauma was induced and chlorogenic acid treatment was started in group C (n=7). Blood samples were collected to analyze baseline values and the 12th h, 1st day, 3rd day, and 5th day catalase, native thiol (NT), total thiol (TT), disulfide (SS), SS/TT, SS/NT, and NT/TT levels. Functional analysis with Basso-Beattie and Bresnahan scores was performed at the same time points. Total antioxidant status (TAS), total oxidative stress, oxidative stress index, and cyclooxygenase-2 (Cox-2) were examined in the spinal cord of rats euthanized on day 7; results were statistically analyzed.

Results

On day 7, catalase levels in Group C were significantly higher than baseline levels, whereas those in Group T were significantly lower than baseline levels; Group L showed no significant difference (p=0.008). SS values on day 7 were lower in Group T than in Groups C and L. Group C showed the lowest decrease in NT/TT level after trauma. On day 7, SS/TT level was high in Group T but stable in Groups C and L (p=0.04). Histopathological examination revealed significantly lower Cox-2 and TAS levels in Group C than in Group T (p=0.003, p=0.017, respectively).

Conclusion

In this study, SCI was primarily examined through thiol-SS balance, and it was demonstrated by experimental models that chlorogenic acid has antioxidant and neuroprotective effects in SCI.

Free full text 


Logo of tjtesLink to Publisher's site
Ulus Travma Acil Cerrahi Derg. 2022 Feb; 28(2): 125–133.
Published online 2022 Feb 1. https://doi.org/10.14744/tjtes.2020.89499
PMCID: PMC10443138
PMID: 35099038

Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?

ABSTRACT

BACKGROUND:

We aimed to investigate antioxidant and neuroprotective properties of chlorogenic acid in spinal cord injury (SCI).

METHODS:

Twenty-one rats were divided into three groups. Laminectomy was performed in group L (n=7), spinal cord trauma was induced in group T (n=7), and spinal cord trauma was induced and chlorogenic acid treatment was started in group C (n=7). Blood samples were collected to analyze baseline values and the 12th h, 1st day, 3rd day, and 5th day catalase, native thiol (NT), total thiol (TT), disulfide (SS), SS/TT, SS/NT, and NT/TT levels. Functional analysis with Basso-Beattie and Bresnahan scores was performed at the same time points. Total antioxidant status (TAS), total oxidative stress, oxidative stress index, and cyclooxygenase-2 (Cox-2) were examined in the spinal cord of rats euthanized on day 7; results were statistically analyzed.

RESULTS:

On day 7, catalase levels in Group C were significantly higher than baseline levels, whereas those in Group T were significantly lower than baseline levels; Group L showed no significant difference (p=0.008). SS values on day 7 were lower in Group T than in Groups C and L. Group C showed the lowest decrease in NT/TT level after trauma. On day 7, SS/TT level was high in Group T but stable in Groups C and L (p=0.04). Histopathological examination revealed significantly lower Cox-2 and TAS levels in Group C than in Group T (p=0.003, p=0.017, respectively).

CONCLUSION:

In this study, SCI was primarily examined through thiol-SS balance, and it was demonstrated by experimental models that chlorogenic acid has antioxidant and neuroprotective effects in SCI.

Keywords: Chlorogenic acid, oxidative stress, spinal cord injury, thiol/disulfide

INTRODUCTION

Spinal cord injury (SCI) can cause primary injury which initially occurs due to the acute effect of trauma, followed by development of the secondary injury. In primary damage caused by mechanical damage, oxidative stress occurs as a result of cellular events in the cytoplasm and mitochondria and persists during secondary damage due to ongoing neuroinflammation.[13] One of the last measurable parameters of oxidative stress is thiol-disulfide (SS) levels. Thiols are in equilibrium with their SS forms in plasma. Many studies have shown a correlation between thiol-SS levels and the severity, type, and outcome of body damage.[48]

Chlorogenic acid (5-0-caffeoylquinic acid, [5CQA]) is a phytochemical substance found in coffee and coffee beans. It has antidiabetic, antioxidant, anti-inflammatory, antimicrobial, and antihyperlipidemic bioactivities.[3,913] Experimental studies have shown that it stops cell growth in tumors and does not cause toxicity even at high doses.[14] Furthermore, brain studies have shown that it has protective effects against ischemia.[9,15,16] The main factors that increase complications in post-traumatic SCI are increased oxidant capacity, ischemia, infection, diabetes as a comorbidity, and obesity. Another possible theory is that 5CQA reduces damage in SCI due to its antidiabetic, anti-inflammatory, and antimicrobial activities. 5CQA can also protect dopaminergic neurons by suppressing neuroinflammation.[17]

Based on the above-mentioned information, we functionally, biochemically, and histopathologically investigated the effects of chlorogenic acid in an experimental SCI model.

MATERIALS AND METHODS

Wistar-Hannover albino adult female rats (weighing 250–300 g, n=21) were divided into three groups. During the experiment, all groups were held in a standard postoperative care room (at 20–25°C, 50–60% humidity, in polycarbonate cages) with standard feeding conditions and 12-h light and dark cycles.

A commercial kit was used for measurement of total antioxidant status (TAS) and total oxidative status in tissue.[18,19] The protein level of tissue was determined using the Lowry method.[20] Oxidative Stress Index (OSI) was obtained by dividing total oxidant capacity (TOS) values by TAS values (OSI [Arbitrary Unit] = [TOS, μmol H2O2 eq/L]/[TAS, μmol Trolox eq/L]).

Serum thiol SS was measured by an automatic analyzer (Roche, cobas 501, Mannheim, Germany) using the method created by Erel and Neşelioğlu. In this method, SS bonds in the sample were converted to functional thiol groups by NaBH4. The total thiol (TT) content in the sample was calculated using Ellman reagent. The serum SS level was determined with the formula (serum TT − serum native thiol [NT])/2.[5]

Study Design

Wistar-Hannover albino adult female rats (weighing 250–300 g, n=21) were divided into three groups with seven randomly selected rats in each group. During the experiment, all groups were held in a standard post-operative care room (at 20–25°C, 50–60% humidity, in polycarbonate cages) with standard feeding conditions and 12-h light and dark cycles. T 7-8-9 laminectomy was performed on the rats in the control group (Group L, laminectomy group). After laminectomy was performed on the rats in the trauma group (Group T; trauma group), trauma was induced with the modified Allen weight dropping model (using a 10-cm long glass tube with a diameter of 0.5 cm, 10 g of weight was dropped on solid dura from a height of 10 cm). Following laminectomy and trauma induction, rats in the treatment group (Group C, chlorogenic acid group) received 60 mg/kg/day chlorogenic acid (Sigma-Aldrich, St. Louis, MO, USA) by gastric lavage, with the initial dose given immediately after trauma at the 15th min.

Surgical Procedure

After 6 h of fasting, 1 mg/kg ketamine (Ketalar, Pfizer, New York, USA) and 1 mg/kg xylazine (Alfazyne, Alfasan, Woerden, Netherland) were intraperitoneally administered, and the rats were left for spontaneous breathing at a suitable room temperature. Rats were fixed face down, their T7-8-9 levels were determined, and they were cleaned before surgery. Antisepsis was provided with Povidone-iodine. A midline incision was made, skin and subcutaneous tissue were crossed, and paravertebral muscles were subperiosteally dissected. After T7-8-9 laminectomy, the procedures described above were performed for each group. All rats were closed in line with anatomical integrity after the procedure. Rats were euthanized on the 7th day.

Functional Analysis

Basso-Beattie and Bresnahan scores were evaluated in all rats on postoperative 12 h, day 1, day 3, day 5, and day 7. The results were evaluated statistically.

Biochemical Analysis

Tail blood samples were taken before anesthesia induction, and at 12th h, 1st day, 5th day, and 7th day after the surgical procedure. Albumin, catalase, ischemia-modified albumin, and thiol-SS balance were examined by the spectrophotometric method. After the rats were euthanized, spinal cord tissue in the T7-8-9 region was removed, and TOS, TAS, and OSI were studied and statistically evaluated.

Histopathological Analysis

On gross examination perpendicular cut sections of spinal cords were processed and embedded in paraffin blocks. Then, 4-μm sections were deparaffinized in xylene, and rehydrated through a graded series of ethanol in order to perform hematoxylin-eosin staining and immunohistochemistry. Immunohistochemistry was performed using cyclooxygenase-2 (Cox-2) ab (D-12: sc-166475, Santa Cruz Biotechnology, Inc.) with a 1:100 dilution by Leica bond auto-stain system according to manufacturer’s guideline. In this system slides are visualized with 3,3-diaminobenzidine (Fig. 1).

An external file that holds a picture, illustration, etc.
Object name is TJTES-28-125-g001.jpg

Inlets demonstrate the strong cytoplasmic immunohistochemical expression. Although background stain is prominent, the cells with strong expression are counted (a) Group L - Control group, (b) Group T - Trauma group, (c) Group C - Chlorogenic acid group.

A pathologist, who is blind to the groups, examined hematoxylin-eosin stained and immunohistochemically Cox-2 applied sections. Cox-2 positive cells were counted per 3 HPF for each spinal cord.

Statistical Analysis

Data were analyzed using Statistical Package for the Social Sciences (SPSS) 15 (SPSS Inc; Chicago; IL, USA) software. The suitability of numerical variables to normal distribution was examined by Kolmogorov–Smirnov tests. The difference between independent groups was analyzed with the Kruskal–Wallis test followed by the Mann–Whitney U test, and the difference between dependent groups was analyzed with the Friedman test. The results were expressed as mean±SD, and p<0.05 was considered statistically significant.

RESULTS

Investigation of Plasma Levels

There was no statistically significant difference between the groups in terms of baseline plasma values of the markers examined (p>0.005) (Table 1). Although catalase levels did not show a statistically significant difference between the groups at the 12th h, there was an overall decrease in all groups (p=0.489). On day 1, there was a statistically significant difference between the catalase levels of Group L and Groups C and T; catalase levels decreased in Groups C and T, whereas they increased in group L (p=0.003). In Group L, there was no significant change in catalase levels between baseline levels and day 7 (from 77.07±8.63 kU/L to 74.64±9.838 kU/L). There was a decrease in catalase levels in Group T (from 75.71±7.42 kU/L to 48.33±22.25 kU/L) and an increase in Group C (from 77.69±16.95 kU/L to 85.20±9.36 kU/L). In addition, a statistically significant difference was found between Group T and Group C on day 7 (p=0.008). This pattern was the same when evaluated according to the 12th h. When the change in catalase levels was examined within the groups over time, there was no statistically significant difference in Group L (p=0.296), but there was a statistically significant difference in Group T and Group C (p=0.041, p<0.001, respectively) (Table 1 and Fig. 2).

Table 1

Oxidative and antioxidative state of the rats

ParametersGroupBaselineTimep-value

12th h1st day3rd day5th day7th day
CatalaseL77.07±8.6355.50±32.7076.67±13.6770.04±13.0766.00±12.8574.64±9.380.296
T75.709±7.4275.59±12.2563.01±18.7458.08±11.0359.77±13.548.33±22.250.041
C77.69±16.9574.83±8.9937.39±9.9186.96±7.2961.00±12.6185.20±9.36<0.001
p-value0.7130.4890.003y,z0.002y,z0.5220.008z
Native Thiol (umol/l)L186.15±35.88101.45±35.19113.66±18.8872.28±13.03167.33±34.1088.92±20.98<0.001
T186.70±45.05211.52±40.1089.84±22.44130.27±25.72131.72±31.50166.82±23.29<0.001
C186.67±21.08137.08±16.27130.05±41.47118.84±6.09107.34±36.1581.62±23.38<0.001
p-value0.9530.001x,z0.1390.001x,y0.02y0.001x,z
Total Thiol (umol/l)L254.81±52.54177.98±46.04156.18±20.37149.07±19.08215.65±41.68161.74±24.630.04
T244.40±59.62266.94±41.36167.03±38.91211.91±35.67218.37±48.10238.07±339.810.045
C261.01±30.79214.30±37.40190.35±47.62169.08±24.52187.88±42.72131.07±19.33<0.001
p-value0.9320.005x,z0.3870.007x,z0.4370.001x,y,z
Disulfide (umol/l)L34.32±10.8838.26±9.3221.26±6.0538.39±9.7324.26±5.0936.40±8.650.005
T28.85±11.2727.70±7.2638.59±12.7140.82±13.2143.21±17.4635.62±11.070.23
C37.17±18.3738.60±13.3430.15±14.3825.12±.9.3240.27±7.7824.72±7.410.025
p-value0.6670.1300.028x0.028y,z0.009y0.111
Native Thiol/L73.44±5.0556.30±6.9272.74±7.2948.76±8.767.48±2.8354.86±8.83<0.001
Total Thiol (%)T76.67±5.2678.96±5.6154.02±8.9961.86±9.8561.14±11.8870.49±5.500.001
C72.34±11.5264.82±7.2567.87±12.6671.15±7.0755.82±7.6461.63±11.900.068
p-value0.4780.001x,y,z0.013x,y,z0.003x,y0.005x,y0.04x
Disulfide/Total Thiol (%)L13.28±2.5221.84±3.4613.62±3.6425.61±4.3811.25±1.4122.56±4.41<0.001
T11.66±2.6310.52±2.8022.98±4.4919.06±4.9219.43±5.9414.75±2.750.001
C13.82±5.7617.58±3.6216.06±6.3314.42±5.5322.08±3.8217.41±7.440.068
p-value0.4530.001x,y,z0.013x,y,z0.003x,y0.005x,y0.04x
Disulfide/Native Thiol (%)L18.35±4.7339.85±10.0919.36±7.3655.63±20.2614.60±2.343.36±16.29<0.001
T15.49±4.8713.60±4.5644.75±15.6132.72±13.9534.63±17.7521.28±5.340.001
C20.83±12.6927.98±8.9325.94±14.3420.85±6.8641.09±13.0233.70±15.620.068
p-value0.4780.001x,y,z0.013x,y,z0.003x,y,z0.005x,y0.04x
xThere is a statistically significant difference between Group L and Group T.
yThere is a statistically significant difference between Group L and Group C.
zThere is a statistically significant difference between Group T and Group C. The P-value in each column shows the comparison between groups and the P-value in each row shows the comparison within groups.
An external file that holds a picture, illustration, etc.
Object name is TJTES-28-125-g002.jpg

Catalase levels of all groups (mean±SD). Catalase levels decreased in all groups at the 12th h, which was the first measurement point immediately after trauma, but on day 7, catalase levels were higher in the chlorogenic acid group (Group C) and lower in the trauma group (Group T) compared to baseline levels, and no significant difference was observed in the laminectomy group (Group L).

There was no statistically significant difference between the groups in terms of SS levels at the 12th h (p=0.130). However, on day 5, there was a statistically significant difference in SS levels between Group L and Group C and between Group T and Group C (p=0.007). When SS levels at the 12th h and on day 7 were compared, there was a slight and insignificant decrease in Group L (from 38.26±9.32 μmol/l to 36.40±8.65 μmol/l), a significant increase was observed in Group T (from 27.70±7.26 μmol/l to 35.62±11.07 μmol/l), and a significant decrease was observed in Group C (from 38.60±13.34 μmol/l to 24.72±7.41 μmol/l). A similar pattern was observed when the baseline values were compared with the 7th day values (Table 1 and Fig. 3).

An external file that holds a picture, illustration, etc.
Object name is TJTES-28-125-g003.jpg

Disulfide levels of all groups (mean±SD) sulfide values increased in laminectomy and chlorogenic acid groups at the 12th h, the earliest measurement point after injury in the experiments, compared to baseline values, and showed a slight decrease in the trauma group, which was statistically insignificant. On day 7, disulfide values were higher in the trauma group compared to the 12th h values; whereas they were lower in the chlorogenic acid group compared to the 12th h values.

When SS/TT, SS/NT, and NN/TT values were compared between the 12th h and 7th day, a decrease was observed in all groups. However, this decrease was lowest in Group L (from 56.30±6.92 to 54.86±8.83), followed by Group C (from 64.82±7.25 to 61.63±11.90), and then by Group T. In terms of SS/TT values, Groups L and C followed a similar pattern while Group T followed a different pattern. When the 12th h values were compared with the 7th day values, there was no significant change in Group L (from 21.84±3.46 to 22.56±4.41) and Group C (from 17.58±3.62 to 17.41±7.44), whereas a significant increase was observed in Group T (from 10.52±2.80 to 14.74±2.75). A significant difference was observed between SS/NT, SS/TT, and NT/TT values at h 12 and day 1 between Group L and Groups T and C and between Groups T and C (p=0.001 for h 12, p=0.013 for day 1). A significant difference was found in day 3 and day 5 values only between Group L and Groups T and C (p=0.003 and p=0.005, respectively), and finally, on day 7, a statistically significant difference was found only between Group L and Group T (p=0.004). There was no longer any statistically significant difference between Group L and Group C (Table 1).

Tissue-level Investigations

Histopathological Examination

No statistically significant difference was found between the TOS and OSI levels following an examination after the rats were euthanized (p=0.107 and p=0.214, respectively). There was a statistically significant difference in TAS between Group T and Groups L and C (p=0.017). While the highest TAS values were obtained in Group C (36.27±6.96 nm Trolox Eqv/mg protein), the lowest TAS values were obtained in Group T (28.97±2.135 nm Trolox Eqv/mg protein) (Table 2 and Fig. 4).

Table 2

TAS, TOS, OSI, and Cox-2 values (mean±SD) measured from the spinal cord tissue

Group LGroup TGroup Cp-value
TAS (nmTroloxEqv/mg pro-tein)33.41±3.0628.97±2.13536.27±6.960.017
TOS (nmol H2o2Eqv/mg pro-tein)0.75±0.170.78±0.230.97±0.230.107
OSI (TOS/TAS)0.021±0.0040.026±0.0080.029±0.0.1070.214
Cox216.85±2.6021.85±2.419.28±6.920.003

TAS: Total antioxidant status; TOS: Total oxidant status; OSI: Oxidative stress index; Cox-2: Cyclooxygenase-2; SD: Standard deviation. Group L: Control group, Group T: Trauma group, Group C: Chlorogenic acid group. xThere is a statistically significant difference between group L and group T. yThere is a statistically significant difference between group L and group C. zThere is a statistically significant difference between group T and group C.

An external file that holds a picture, illustration, etc.
Object name is TJTES-28-125-g004.jpg

Total antioxidant status levels of all groups (mean±SD).

Cox-2 levels were significantly lower in Group C compared to Groups T and L (p=0.003). The highest Cox-2 levels were observed in Group T (21.85±2.41), whereas the lowest values were observed in group C (9.28±6.92) (Table 2 and Fig. 5).

An external file that holds a picture, illustration, etc.
Object name is TJTES-28-125-g005.jpg

Cyclooxygenase-2 (Cox-2) results of all groups (mean±SD). Cox-2 levels were statistically significantly lower in the group treated with chlorogenic acid compared to the trauma group (p=0.003).

Functional Results

When all the groups were evaluated functionally, there was a statistically significant difference between Group L and Groups T and C in terms of 12th h, 1st day, 3rd day, and 5th day results (p=0.001, p=0.003, p=0.001, and p<0001, respectively). On the 7th day, a significant functional improvement was observed in group C, but there was no statistically significant difference between Group C and Group L. On the other hand, the statistically difference between Group C and Group T was still significant. The significant difference between Group T and Group L continued as observed at other time points (p<0.001) (Table 3).

Table 3

Basso-Beattie and Bresnahan scores of the rats evaluated functionally

TimeGroup LGroup TGroup Cp-value
12th hour6.57±0.534.57±1.273±1.820.001x,y
1st day12.71±0.4810.57±1.5110.71±1.600.003x,y
3rd day13±010.57±1.5111.14±1.570.001x,y
5th day13±011±1.5211.71±0.75<0.001x,y
7th day21±017.85±2.1120.57±0.78<0.001x,z
p-value0.001<0.001<0.001

XThere is a statistically significant difference between Group L and Group T. yThere is a statistically significant difference between Group L and Group C. zThere is a statistically significant difference between Group T and Group C.

DISCUSSION

Treatment efforts for SCI have primarily focused on reducing secondary damage. Free oxygen radicals, such as O- and OH- that increase as a result of damage, are one of the main elements in reducing secondary injury. O- and OH- ions are highly active free radicals involved in cell metabolism. These are eliminated after being converted into O2 and H2O with the help of antioxidants such as ascorbic acid, glutathione, and Vitamin E, and enzymes such as superoxide dismutase (SOD), glutathione peroxidase, and especially catalase.

An external file that holds a picture, illustration, etc.
Object name is TJTES-28-125-g006.jpg

5CQA, which is a phytochemical substance, has been shown to have antidiabetic, antioxidant, anti-inflammatory, antimicrobial, and antihyperlipidemic activities.[3,913] Studies have shown that chlorogenic acid has an effect in oxidative stress through electron loss and protein transfer.[21] Furthermore, studies on the central nervous system have shown that it has protective effects against ischemia.[22] Chlorogenic acid can also protect dopaminergic neurons by suppressing neuroinflammation.[17]

An external file that holds a picture, illustration, etc.
Object name is TJTES-28-125-g007.jpg

The antioxidant defense system protects the cell by neutralizing harmful effects of oxidants and free radicals. Catalase, one of the important antioxidant enzymes,[2325] is used as an indicator of damage severity and responses to therapy as well as for follow-up in therapeutic studies.[2428] In the present study, catalase levels decreased in all groups at the 12th h, which was the first measurement point immediately after trauma, and continued to decrease on day 1 in trauma, but on day 7, catalase levels were higher in the chlorogenic acid group and lower in the trauma group compared to baseline levels, and no significant difference was observed in the laminectomy group. Although the level of antioxidant catalase decreased in response to trauma in the early period, it increased in the group treated with chlorogenic acid in the subsequent period, but decreased in the trauma group (Table 1 and Fig. 2). This result shows that chlorogenic acid increases antioxidant catalase levels after SCI. Similarly, in our tissue studies, the highest TAS values were obtained in Group C, the lowest TAS values were obtained in group T (Table 2 and Fig. 4). This result shows that chlorogenic acid also increases TAS levels after SCI in the spinal cord tissue.

The spinal cord contains high levels of antioxidants.[2931] After SCI, a decrease in SOD and endogenous antioxidants leads to excessive accumulation of free radicals. This damages cellular lipids, proteins, and DNA. Free radicals play an important role in traumatic and ischemic spinal cord injuries.[2932] Free radicals form on damaged cell membranes and continue to damage the membrane as the cycle continues until the endogenous antioxidants, SOD, are blocked by Vitamin E. Cellular damage occurs when a proper antioxidant response cannot be obtained and eventually leads to oxidative stress.[33] Ca++ influx to the cell leads to arachidonic acid release. Increased extracellular excitatory neurotransmitters stimulate neuronal activation. This leads to the release of Cox-2 from cortical neurons. Selective inhibition of Cox-2 has been shown to facilitate recovery after SCI in various animal experiments.[34] In the present study, the effectiveness of chlorogenic acid at tissue level was evaluated by measuring Cox-2, TAS, TOS, and OSI levels in tissue. Cox-2 levels were statistically significantly lower in the group treated with chlorogenic acid compared to the trauma group (p=0.003) (Table 2 and Fig. 5). Chlorogenic acid was seen to facilitate healing by lowering Cox-2 levels at the tissue level.

Thiol is an organic compound that contains a sulfhydryl group and is an important component of the antioxidant system. The plasma thiol pool comprises largely of albumin and protein thiols, and to a lesser extent, low molecular weight thiols such as cysteine (Cys). Thiols can form SSs through oxidation reactions. In the case of oxidative stress, reversible mix SS formation can occur between protein thiol groups and low molecular weight thiols by oxidation of Cys residues. The resulting SS can be reduced back to thiol groups, preserving dynamic thiol SS homeostasis.[4,5,7] The amount of SS formed is one of the parameters that highlight increased oxidative stress. It is used as a parameter to indicate the severity of damage in studies on thiol SS balance.[48,18] In the present study, thiol-SS parameters were used to evaluate the effectiveness of chlorogenic acid on oxidant-antioxidant capacity after SCI.

According to the results of this study, SS values increased in laminectomy and chlorogenic acid groups at the 12th h, the earliest measurement point after injury in the experiments, compared to baseline values, and showed a slight decrease in the trauma group, which was statistically insignificant. However, at the subsequent time points, SS values increased in the trauma group. On day 7, SS values were higher in the trauma group compared to the 12th h values; whereas they were lower in the chlorogenic acid group compared to the 12th h values (Table 1 and Fig. 3). Since SS is expected to increase when oxidative stress increases, low SS values found in the treatment group reveal that chlorogenic acid may have a positive effect on recovery. In addition, the NT/TT ratio decreased on day 7 compared to the 12th h in all groups. However, while there was a statistically significant difference between laminectomy group and trauma and chlorogenic acid groups at the 12th h (p=0.001), there was a significant difference observed on day 7 between the laminectomy and trauma groups (p=0.04), and the significant difference between the laminectomy and the chlorogenic acid groups disappeared (p>0.005). In addition, when the NT/TT ratios on day 7 were compared to the 12th h values, the lowest decrease was observed in the laminectomy group, followed by the chlorogenic acid and trauma groups, respectively. Since a lower decrease in NT/TT positively contributes to recovery of the damage, better results were observed in the chlorogenic acid group compared to the trauma group. In terms of the SS/TT ratio, higher levels were observed in the trauma group on day 7, while no significant changes were observed in the laminectomy and chlorogenic acid groups. Since an increase in SS/NT ratio is a negative parameter for a damaged tissue, its increase in the trauma group after injury compared to no change in the chlorogenic acid group suggests that chlorogenic acid had a protective effect in the treatment group by keeping the SS/NT ratio stable.

Up until day 5, there was a statistical difference between the laminectomy group and the trauma and chlorogenic acid groups in terms of functional results, but there was no difference between the trauma and the chlorogenic acid groups. However, on day 7, a significant improvement was observed in the chlorogenic acid group compared to the trauma group (p<0.001) (Table 3). As a result, better functional results were obtained in the group treated with chlorogenic acid compared to the trauma group.

Conclusion

The severity of oxidative stress seen during primary and secondary damage following SCI is directly proportional to the severity of the damage. Oxidative-antioxidative homeostasis has, therefore, been a primary focus for therapeutic studies. Thiol-SS balance is one of the most important parameters indicating oxidative stress. In this article, the therapeutic efficacy of chlorogenic acid in SCI was also evaluated in terms of Thiol/SS balance. The effect of chlorogenic acid on oxidative stress was evaluated at both plasma and tissue levels. According to the results, chlorogenic acid reduces oxidative stress in SCI and shows antioxidative and neuroprotective properties.

Footnotes

Ethics Committee Approval: Ethical approval for this study was obtained from the local ethics committee of Kobay AŞ (No: 279). All applicable international, national, and institutional guidelines for the care and use of animals were followed. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed (Date: 23.03.2018).

Peer-review: Internally peer-reviewed.

Authorship Contributions: Concept: E.B., C.B., A.Ş., B.G., B.B., Ö.F.T.; Design: E.B., C.B., A.Ş., B.G., B.B., Ö.F.T.; Supervision: E.B., C.B., A.Ş., B.G., B.B., Ö.F.T.; Resource: E.B., Ş.H., A.S.A., B.G., B.B., Ö.F.T.; Materials: E.B., Ş.H., A.S.A., B.G., B.B., Ö.F.T.; Data: E.B., Ş.H., A.S.A., B.G., B.B., Ö.F.T.; Analysis: E.B., Ş.H., A.S.A., C.B., A.Ş., B.G.; Literature search: EE.B., Ş.H., A.S.A., C.B., A.Ş., B.G.; Writing: E.B., Ş.H., A.S.A., C.B., A.Ş., B.G., B.B., Ö.F.T.; Critical revision: E.B., C.B., A.Ş., B.B., Ö.F.T.

Conflict of Interest: None declared.

Financial Disclosure: This study was funded by Ankara Yildirim Beyazit University, grant number 4887. The sponsor had no role in the design or conduct of this research.

REFERENCES

1. Liu J, Peng L, Li J. The lipoxin A4 receptor agonist BML-111 alleviates inflammatory injury and oxidative stress in spinal cord injury. Med Sci Monit. 2020;26:e919883. [Europe PMC free article] [Abstract] [Google Scholar]
2. Liu Z, Yao X, Jiang W, Li W, Zhu S, Liao C, et al. Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-kappaB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuroinflammation. 2020;17:90. [Europe PMC free article] [Abstract] [Google Scholar]
3. Lou L, Zhou J, Liu Y, Wei YI, Zhao J, Deng J, et al. Chlorogenic acid induces apoptosis to inhibit inflammatory proliferation of IL-6-induced fibroblast-like synoviocytes through modulating the activation of JAK/STAT and NF-kappaB signaling pathways. Exp Ther Med. 2016;11:2054–60. [Europe PMC free article] [Abstract] [Google Scholar]
4. Erel O, Erdogan S. Thiol disulfide homeostasis:An integrated approach with biochemical and clinical aspects. Turk J Med Sci. 2020;50:1728–38. [Europe PMC free article] [Abstract] [Google Scholar]
5. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47:326–32. [Abstract] [Google Scholar]
6. Giden R, Gokdemir MT, Erel O, Buyukaslan H, Karabag H. The relationship between serum thiol levels and thiol/disulfide homeostasis with head trauma in children. Clin Lab. 2018;64:163–8. [Abstract] [Google Scholar]
7. Gunduztepe Y, Bukan N, Zorlu E, Karaman Y, Topkan TA, Gurbuz N, et al. The evaluation of thiol-disulfite balance, ischemia albumin modification and seruloplazmine as a new oxidative stress in mild cognitive impairment and early stage alzheimer's disease patients. J Clin Neurosci. 2020;75:188–94. [Abstract] [Google Scholar]
8. Ivanov AV, Alexandrin VV, Paltsyn AA, Nikiforova KA, Virus ED, Luzyanin BP, et al. Plasma low-molecular-weight thiol/disulphide homeostasis as an early indicator of global and focal cerebral ischaemia. Redox Rep. 2017;22:460–6. [Europe PMC free article] [Abstract] [Google Scholar]
9. Liu D, Wang H, Zhang Y, Zhang Z. Protective effects of chlorogenic acid on cerebral ischemia/reperfusion injury rats by regulating oxidative stress-related Nrf2 pathway. Drug Des Dev Ther. 2020;14:51–60. [Europe PMC free article] [Abstract] [Google Scholar] Retracted
10. Lou Z, Wang H, Zhu S, Ma C, Wang Z. Antibacterial activity and mechanism of action of chlorogenic acid. J Food Sci. 2011;76:M398–403. [Abstract] [Google Scholar]
11. Naveed M, Hejazi V, Abbas M, Kamboh AA, Khan GJ, Shumzaid M, et al. Chlorogenic acid (CGA):A pharmacological review and call for further research. Biomed Pharmacother. 2018;97:67–74. [Abstract] [Google Scholar]
12. Stefanello N, Schmatz R, Pereira LB, Rubin MA, da Rocha JB, Facco G, et al. Effects of chlorogenic acid, caffeine, and coffee on behavioral and biochemical parameters of diabetic rats. Mol Cell Biochem. 2014;388:277–86. [Abstract] [Google Scholar]
13. Tajik N, Tajik M, Mack I, Enck P. The potential effects of chlorogenic acid, the main phenolic components in coffee, on health:A comprehensive review of the literature. Eur J Nutr. 2017;56:2215–44. [Abstract] [Google Scholar]
14. Huang S, Wang LL, Xue NN, Li C, Guo HH, Ren TK, et al. Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation. Theranostics. 2019;9:6745–63. [Europe PMC free article] [Abstract] [Google Scholar]
15. Hermawati E, Arfian N, Mustofa M, Partadiredja G. Chlorogenic acid ameliorates memory loss and hippocampal cell death after transient global ischemia. Eur J Neurosci. 2020;51:651–69. [Abstract] [Google Scholar]
16. Wang S, Wei H, Cai M, Lu Y, Hou W, Yang Q, et al. Genistein attenuates brain damage induced by transient cerebral ischemia through up-regulation of ERK activity in ovariectomized mice. Int J Biol Sci. 2014;10:457–65. [Europe PMC free article] [Abstract] [Google Scholar]
17. Shen W, Qi R, Zhang J, Wang Z, Wang H, Hu C, et al. Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons. Brain Res Bull. 2012;88:487–94. [Abstract] [Google Scholar]
18. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37:277–85. [Abstract] [Google Scholar]
19. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–11. [Abstract] [Google Scholar]
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75. [Abstract] [Google Scholar]
21. Tosovic J, Markovic S, Markovic JM, Mojovic M, Milenkovic D. Antioxidative mechanisms in chlorogenic acid. Food Chem. 2017;237:390–8. [Abstract] [Google Scholar]
22. Miao M, Cao L, Li R, Fang X, Miao Y. Protective effect of chlorogenic acid on the focal cerebral ischemia reperfusion rat models. Saudi Pharm J. 2017;25:556–63. [Europe PMC free article] [Abstract] [Google Scholar]
23. Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39:73–82. [Abstract] [Google Scholar]
24. Nandi A, Yan LJ, Jana CK, Das N. Role of catalase in oxidative stress and age-associated degenerative diseases. Oxid Med Cell Longev. 2019;2019:9613090. [Europe PMC free article] [Abstract] [Google Scholar]
25. Vaziri ND, Lee YS, Lin CY, Lin VW, Sindhu RK. NAD(P)H oxidase, superoxide dismutase, catalase, glutathione peroxidase and nitric oxide synthase expression in subacute spinal cord injury. Brain Res. 2004;995:76–83. [Abstract] [Google Scholar]
26. Kodydkova J, Vavrova L, Kocik M, Zak A. Human catalase, its polymorphisms, regulation and changes of its activity in different diseases. Folia Biol (Praha) 2014;60:153–67. [Abstract] [Google Scholar]
27. Kong G, Huang Z, Ji W, Wang X, Liu J, Wu X, et al. The ketone metabolite beta-hydroxybutyrate attenuates oxidative stress in spinal cord injury by suppression of Class I histone deacetylases. J Neurotrauma. 2017;34:2645–55. [Abstract] [Google Scholar]
28. Samarghandian S, Azimi-Nezhad M, Farkhondeh T, Samini F. Anti-oxidative effects of curcumin on immobilization-induced oxidative stress in rat brain, liver and kidney. Biomed Pharmacother. 2017;87:223–9. [Abstract] [Google Scholar]
29. Bao F, Liu D. Peroxynitrite generated in the rat spinal cord induces apoptotic cell death and activates caspase-3. Neuroscience. 2003;116:59–70. [Abstract] [Google Scholar]
30. Hall ED. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics. 2011;8:152–67. [Europe PMC free article] [Abstract] [Google Scholar]
31. Lu J, Ashwell KW, Waite P. Advances in secondary spinal cord injury:Role of apoptosis. Spine (Phila Pa 1976) 2000;25:1859–66. [Abstract] [Google Scholar]
32. Klusman I, Schwab ME. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res. 1997;762:173–84. [Abstract] [Google Scholar]
33. Singh E, Devasahayam G. Neurodegeneration by oxidative stress:A review on prospective use of small molecules for neuroprotection. Mol Biol Rep. 2020;47:3133–40. [Abstract] [Google Scholar]
34. Dumont RJ, Verma S, Okonkwo DO, Hurlbert RJ, Boulos PT, Ellegala DB, et al. Acute spinal cord injury, part II:Contemporary pharmacotherapy. Clin Neuropharmacol. 2001;24:265–79. [Abstract] [Google Scholar]

Articles from Turkish Journal of Trauma & Emergency Surgery are provided here courtesy of Turkish Association of Trauma and Emergency Surgery

Citations & impact 


Impact metrics

Jump to Citations

Article citations

Similar Articles 


To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.